Loading
JPXConsumer CyclicalPersonal Products & Services
Latest quote
¥1,011
+¥7.00 · +0.70%
Japan Animal Referral Medical Center Co., Ltd. operates a network of animal medical facilities across Japan, specializing in delivering advanced veterinary care for dogs and cats. These comprehensive centers boast an extensive range of specialized departments, from cardiology, respiratory, urology, and gastroenterology to oncology, neurology, orthopedics, ophthalmology, diagnostic imaging, and anesthesiology. Beyond direct patient care, the company also offers professional training, encompassing clinical instruction and treatment practices. Furthermore, it actively engages in research and development initiatives, exploring fields such as genetic testing, immunotherapy, and regenerative medicine. The firm, established in 2005, has its headquarters located in Kawasaki, Japan.
Latest quote
¥1,011
+¥7.00 · +0.70%
Regular session · JST · Market data may be delayed.
Japan Animal Referral Medical Center Co., Ltd. operates a network of animal medical facilities across Japan, specializing in delivering advanced veterinary care for dogs and cats. These comprehensive centers boast an extensive range of specialized departments, from cardiology, respiratory, urology, and gastroenterology to oncology, neurology, orthopedics, ophthalmology, diagnostic imaging, and anesthesiology. Beyond direct patient care, the company also offers professional training, encompassing clinical instruction and treatment practices. Furthermore, it actively engages in research and development initiatives, exploring fields such as genetic testing, immunotherapy, and regenerative medicine. The firm, established in 2005, has its headquarters located in Kawasaki, Japan.
Day range
Current ¥1,011
52-week range
Current ¥1,011
Regular session · JST · Market data may be delayed.
Japan Animal Referral Medical Center Co., Ltd. operates a network of animal medical facilities across Japan, specializing in delivering advanced veterinary care for dogs and cats. These comprehensive centers boast an extensive range of specialized departments, from cardiology, respiratory, urology, and gastroenterology to oncology, neurology, orthopedics, ophthalmology, diagnostic imaging, and anesthesiology. Beyond direct patient care, the company also offers professional training, encompassing clinical instruction and treatment practices. Furthermore, it actively engages in research and development initiatives, exploring fields such as genetic testing, immunotherapy, and regenerative medicine. The firm, established in 2005, has its headquarters located in Kawasaki, Japan.
Day range
Current ¥1,011
52-week range
Current ¥1,011
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 6.19B JPY | 5.28B JPY | 4.27B JPY | 3.87B JPY | 2.98B JPY |
| Cost of goods sold | 3.69B JPY | 3.47B JPY | 2.84B JPY | 2.47B JPY | 1.91B JPY |
| Gross profit | 2.51B JPY | 1.81B JPY | 1.43B JPY | 1.41B JPY | 1.07B JPY |
| Research and development | — | 8.88M JPY | 7.55M JPY | — | — |
| Selling, general, and administrative | 1.36B JPY | 992.58M JPY | 859.9M JPY | 754.36M JPY | 574M JPY |
| Operating expenses | 1.36B JPY | 1.09B JPY | 937.36M JPY | 822.53M JPY | 633.62M JPY |
| Interest expense | 39.92M JPY | 29.97M JPY | 22.09M JPY | 21.84M JPY | 24.22M JPY |
| Depreciation and amortization | 588.66M JPY | 570.68M JPY | 464.47M JPY | 411.84M JPY | 241M JPY |
| Operating income | 1.15B JPY | 720.98M JPY | 496.92M JPY | 584.89M JPY | 439.27M JPY |
| Net income | 833.43M JPY | 520.98M JPY | 337.22M JPY | 380.66M JPY | 286.94M JPY |
Company facts updated Sep 5, 2026.
Recent quarterly results
Recent quarterly results
Cash distributions grouped by calendar year; partial years are marked.
¥7.342
2025 complete year+83.5% since 2024
2026 partial: ¥12.00
¥4.00
2,024
¥7.342
2,025
¥12.00
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
DividendUpcoming | Mar 30, 2027 | ¥13.00Annual | Mar 31, 2027 | Mar 30, 2027 |
Dividend | Mar 30, 2026 | ¥12.00Annual | Mar 31, 2026 | Jun 10, 2026 |
Dividend | Mar 28, 2025 | ¥36.71Annual | Mar 31, 2025 | Jun 11, 2025 |
Dividend | Mar 28, 2024 | ¥20.00Annual | Mar 31, 2024 | Jun 12, 2024 |
Ex-dividend Mar 30, 2027
¥13.00
Annual
Record Mar 31, 2027 · Payment Mar 30, 2027
Ex-dividend Mar 30, 2026
¥12.00
Annual
Record Mar 31, 2026 · Payment Jun 10, 2026
Ex-dividend Mar 28, 2025
¥36.71
Annual
Record Mar 31, 2025 · Payment Jun 11, 2025
Ex-dividend Mar 28, 2024
¥20.00
Annual
Record Mar 31, 2024 · Payment Jun 12, 2024
Funds reporting this stock among their holdings, ordered by reported position size.
Dimensional - International Core Equity 2 ETFDFIC83.98K0.00%15.37B USD0.22%$39.475-0.01%
Dimensional World ex U.S. Core Equity 2 ETFDFAX41.99K0.00%12.55B USD0.28%$38.61+0.44%
Dimensional - International Core Equity Market ETFDFAI32.95K0.00%18.17B USD0.18%$43.41-0.07%
Dimensional - International Small Cap ETFDFIS9.69K0.00%5.86B USD0.39%$37.67+0.13%Dimensional - International Core Equity 2 ETFDFICDimensional World ex U.S. Core Equity 2 ETFDFAXDimensional - International Core Equity Market ETFDFAIDimensional - International Small Cap ETFDFISAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
